These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8336400)

  • 61. Variant of adynamic bone disease in hemodialysis patients: fact or fiction?
    Rocha LA; Higa A; Barreto FC; dos Reis LM; Jorgetti V; Draibe SA; Carvalho AB
    Am J Kidney Dis; 2006 Sep; 48(3):430-6. PubMed ID: 16931216
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Value of bloodless methods in the study of renal osteodystrophy: comparison with bone histomorphometry].
    González-Posada JM; Torres A; Lorenzo V; Losada M; Maceira B; Hernández Nieto L; Díaz-Flores L
    Med Clin (Barc); 1987 Feb; 88(7):268-73. PubMed ID: 3561071
    [No Abstract]   [Full Text] [Related]  

  • 63. [The effects of estrogen on renal osteodystrophy in the female patients undergoing maintenance hemodialysis].
    Akino H; Saito A; Maeda S; Kitajima W; Okano M; Isomatsu Y; Muranaka K; Kanimoto Y; Shimizu Y; Kawada Y
    Nihon Jinzo Gakkai Shi; 1986 Aug; 28(8):1129-36. PubMed ID: 3807045
    [No Abstract]   [Full Text] [Related]  

  • 64. [Effect of secondary hyperparathyroidism upon serum hydroxyproline in patients with renal failure].
    Mysiak W; Stasiak L
    Pol Arch Med Wewn; 1991 May; 85(5):278-85. PubMed ID: 1896393
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Diagnosis of renal osteodystrophy.
    Schwarz C; Sulzbacher I; Oberbauer R
    Eur J Clin Invest; 2006 Aug; 36 Suppl 2():13-22. PubMed ID: 16884394
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Possible link between changes in plasma 24,25-dihydroxyvitamin D and healing of bone resorption in dialysis osteodystrophy.
    Lambrey G; N'Guyen TM; Garabedian M; Sebert JL; de Fremont JF; Marie P; Caillens C; Gueris J; Meunier P; Balsan S; Fournier A
    Metab Bone Dis Relat Res; 1982; 4(1):25-30. PubMed ID: 6981747
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Detection of early renal osteodystrophy.
    Eke FU; Winterborn MH; Robertson PW
    Child Nephrol Urol; 1988-1989; 9(1-2):33-7. PubMed ID: 3251619
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Assays for parathyroid hormone and their use in patients with end-stage renal disease.
    Goodman WG
    Blood Purif; 2003; 21(1):118-23. PubMed ID: 12596757
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Prediction of radiographic severity of renal osteodystrophy by serum values.
    Guerra LE; Amato JA; Galen MA; Maher JF
    Int Urol Nephrol; 1980; 12(1):65-72. PubMed ID: 7239840
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Measurement of free and total hydroxyproline by automated flow injection of serum or urine samples from maintenance hemodialysis patients with renal osteodystrophy.
    Uji Y; Karmen A; Okabe H; Hata K; Miura M; Ozaki K; Minamizaki M; Shibata T; Inayama S
    J Clin Lab Anal; 1994; 8(5):267-72. PubMed ID: 7807280
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Thermolability of alkaline phosphatase in the evaluation of renal osteodystrophy.
    Sagar S; Borra S; Kaye M
    Nephron; 1971; 8(3):270-7. PubMed ID: 5155279
    [No Abstract]   [Full Text] [Related]  

  • 72. Plasma hydroxyproline fractions in patients with dialysis osteodystrophy.
    Varghese Z; Moorhead JF; Wills MR
    Clin Chim Acta; 1981 Feb; 110(1):105-11. PubMed ID: 7214708
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [A study on the relative factors for secondary parathyroidosis and renal osteodystrophy in long-term hemodialysis patients].
    Pan J; Zhu L; Huang Z
    Zhonghua Nei Ke Za Zhi; 1995 Mar; 34(3):161-4. PubMed ID: 7648935
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Serum and urinary hydroxyproline in patients with severe chronic renal failure.
    Jungiewicz R; Tomaszewski J
    Ann Univ Mariae Curie Sklodowska Med; 1986; 41():67-73. PubMed ID: 3154061
    [No Abstract]   [Full Text] [Related]  

  • 75. Plasma hydroxyproline in uremia: relationships with histologic and biological indices of bone turnover.
    Cundy T; Bartlett M; Bishop M; Earnshaw M; Smith R; Kanis JA
    Metab Bone Dis Relat Res; 1983; 4(5):297-303. PubMed ID: 6621355
    [No Abstract]   [Full Text] [Related]  

  • 76. Is parathyroid hormone measurement useful for the diagnosis of renal bone disease?
    Drüeke TB
    Kidney Int; 2008 Mar; 73(6):674-6. PubMed ID: 18309349
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Clinical significance of free plasma hydroxyproline measurement in metabolic bone disease.
    Minisola S; Antonelli R; Mazzuoli G
    J Clin Chem Clin Biochem; 1985 Sep; 23(9):515-9. PubMed ID: 4067520
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Serum crosslaps as bone resorption marker in peritoneal dialysis.
    Negri AL; Quiroga MA; Bravo M; Marino A; Fradinger E; Bogado CE; Zanchetta JR
    Perit Dial Int; 2002; 22(5):628-30. PubMed ID: 12455578
    [No Abstract]   [Full Text] [Related]  

  • 79. Aluminum and renal osteodystrophy.
    Sherrard DJ
    Semin Nephrol; 1986 Dec; 6(4 Suppl 1):5-11. PubMed ID: 3299591
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Comment on the contribution "Loss of bone substance in long-term dialysis--value of serochemical parameters"].
    Lindenau K; Fröhling PT
    Z Urol Nephrol; 1990 Dec; 83(12):693, 695-6. PubMed ID: 2100096
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.